Time spent commuting to and waiting for health care appointments is a significant contributor to the treatment burden in cancer patients with a shortened life expectancy. A US study assessing the opportunity costs of palliative chemotherapy in 362 patients with metastatic pancreatic ductal adenocarcinoma found just over 50% of total hours devoted to healthcare was ...
Time burden of chemotherapy needs to be considered in decision making
By Mardi Chapman
5 May 2020